Outcome | Cut-off values (µg/L) | Sensitivity (%) | Specificity (%) |
---|---|---|---|
Mortality | |||
Yamazaki et al.56 | 20 | 100 | 73 |
Vos et al.53 | 21.7 | 85 | 48 |
Olivecrona et al.45 | 11.6 | 100 | 45 |
Chabok et al.33 | 51.8 | 100 | 100 |
Zhang et al.59 | 17.6 | 93 | 62 |
Glasgow Outcome Scale ≤ 3 | |||
Raabe et al.48 | 100 | 9 | 96 |
Guan et al.38 | 60 | 54 | 96 |
Zhan et al.58 | 30 | 67 | 83 |
Li et al.40 | 30 | 67 | 77 |
Vos et al.53 | 21.7 | 80 | 55 |
Olivecrona et al.45 | 9.5 | 87 | 36 |
Meric et al.44 | 20.5 | 87 | 82 |
Zhang et al.59 | 16.4 | 87 | 82 |